TrialGynecologic oncology2023

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study.

Krishnansu S Tewari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.